SEC 13F Intelligence

Peapack Gladstone Financial Corp / CVS

Peapack Gladstone Financial Corp’s Cvs Health Corp Position

Does Peapack Gladstone Financial Corp own Cvs Health Corp (CVS)? Yes142.3K shares worth $10M (+0.13% of its 13F portfolio) as of Q1 2026, down from 144.3K shares the prior filed quarter.

Position Value
$10M
Q1 2026
Shares
142.3K
% of Portfolio
+0.13%
Quarters Held
29
currently held

Position History CVS

Reported value by quarter
Q1 ’19: $9MQ1 ’19Q2 ’19: $10MQ3 ’19: $12MQ4 ’19: $14MQ1 ’20: $12MQ1 ’20Q2 ’20: $13MQ3 ’20: $12MQ4 ’20: $15MQ1 ’21: $20MQ1 ’21Q2 ’21: $22MQ3 ’21: $23MQ4 ’21: $28MQ1 ’22: $28MQ1 ’22Q2 ’22: $27MQ3 ’22: $29MQ4 ’22: $27MQ1 ’23: $22MQ1 ’23Q2 ’23: $21MQ3 ’23: $23MQ4 ’23: $25MQ1 ’24: $24MQ1 ’24Q2 ’24: $15MQ3 ’24: $13MQ4 ’24: $8MQ1 ’25: $11MQ1 ’25Q2 ’25: $11MQ3 ’25: $11MQ4 ’25: $11MQ1 ’26: $10MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026142.3K$10M+0.13%
Q4 2025144.3K$11M+0.14%
Q3 2025148.0K$11M+0.15%
Q2 2025159.1K$11M+0.16%
Q1 2025166.7K$11M+0.17%
Q4 2024170.3K$8M+0.11%
Q3 2024208.3K$13M+0.19%
Q2 2024252.5K$15M+0.23%
Q1 2024303.0K$24M+0.38%
Q4 2023322.2K$25M+0.43%
Q3 2023334.1K$23M+0.43%
Q2 2023303.2K$21M+0.37%
Q1 2023293.2K$22M+0.42%
Q4 2022289.5K$27M+0.53%
Q3 2022303.2K$29M+0.59%
Q2 2022286.8K$27M+0.61%
Q1 2022278.3K$28M+0.55%
Q4 2021273.2K$28M+0.53%
Q3 2021271.4K$23M+0.48%
Q2 2021262.2K$22M+0.52%
Q1 2021261.4K$20M+0.51%
Q4 2020213.0K$15M+0.43%
Q3 2020206.2K$12M+0.44%
Q2 2020200.2K$13M+0.51%
Q1 2020197.2K$12M+0.55%
Q4 2019192.6K$14M+0.58%
Q3 2019191.1K$12M+0.52%
Q2 2019175.1K$10M+0.41%
Q1 2019167.7K$9M+0.41%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Peapack Gladstone Financial Corp’s full portfolio or all institutional holders of CVS.